Van Eck Associates Corp Teva Pharmaceutical Industries LTD Transaction History
Van Eck Associates Corp
- $88.3 Billion
- Q2 2025
A detailed history of Van Eck Associates Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Van Eck Associates Corp holds 1,045,605 shares of TEVA stock, worth $20.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,045,605
              Previous 2,320,892
              
        
           54.95%
        
      
          
        Holding current value
$20.5 Million
            Previous $35.7 Million
            
        
           50.87%
        
      
          
        % of portfolio
0.02%
            Previous 0.05%
          
        Shares
	  33 transactions
	
  Others Institutions Holding TEVA
# of Institutions
663Shares Held
664MCall Options Held
30.1MPut Options Held
16.4M- 
    
      Black Rock Inc. New York, NY43MShares$843 Million0.02% of portfolio
- 
    
      Menora Mivtachim Holdings Ltd.38.5MShares$755 Million3.78% of portfolio
- 
    
      Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$752 Million36.86% of portfolio
- 
    
      Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$741 Million5.98% of portfolio
- 
    
      Phoenix Holdings Ltd. Givatayim, L337.8MShares$741 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $21.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...